コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ears, yet how the ancient field was produced is still unknown.
2 ough the role of GH signaling on PVH neurons is still unknown.
3 the human brain represents speech in memory is still unknown.
4 he underlying mechanisms of such integration is still unknown.
5 gnalling drive the precise pattern formation is still unknown.
6 se cell behaviors are regulated individually is still unknown.
7 echanism that links BMP9 with liver diseases is still unknown.
8 behind this net oxidative C-N bond coupling is still unknown.
9 ll defined, the impact of uncommon mutations is still unknown.
10 tions contribute to Alzheimer's disease (AD) is still unknown.
11 mechanism outside the scrutiny of awareness is still unknown.
12 ncy or a tumor- or context-specific response is still unknown.
13 therapy, whether this condition remains true is still unknown.
14 embly of differentially sized soil organisms is still unknown.
15 this task, and its underlying sensory basis, is still unknown.
16 ese cells contribute to CNS antigen drainage is still unknown.
17 er, the origin of its immunological activity is still unknown.
18 mune responses associated with HIV infection is still unknown.
19 dysfunction in neocortical pyramidal neurons is still unknown.
20 ce of IL-10 during M. tuberculosis infection is still unknown.
21 molecules of Dermatophagoides pteronyssinus is still unknown.
22 ormation in vertebrate embryonic development is still unknown.
23 extent of protein loss and phosphoregulation is still unknown.
24 The underlying disease mechanism in TTS is still unknown.
25 + T cells on BECs under a low androgen level is still unknown.
26 underlying cellular and molecular mechanism is still unknown.
27 anges, and their effect on network function, is still unknown.
28 erent cell types; however, its role in VSMCs is still unknown.
29 he NALP3 inflammasome or other inflammasomes is still unknown.
30 on, but which chloride channels are involved is still unknown.
31 ch food, but their behavior during digestion is still unknown.
32 c and dendritic synapses to spike inhibition is still unknown.
33 required to establish this tissue boundary, is still unknown.
34 rather well understood, but the role of DOG1 is still unknown.
35 unction in mammals and adult mammalian cells is still unknown.
36 g that the order parameter of the transition is still unknown.
37 ut whether they use the same Cav1.3 isoforms is still unknown.
38 age-related molecular alterations in plants is still unknown.
39 gan donation and graft function and survival is still unknown.
40 ween plant-herbivore-entomopathogenic fungi, is still unknown.
41 osome could be eliminated by this technology is still unknown.
42 e mechanism by which the virus achieves this is still unknown.
43 however the mechanism underlying this effect is still unknown.
44 blockers on right ventricular (RV) function is still unknown.
45 ter, the largest planet in our Solar System, is still unknown.
46 response and NiV to acute lung injury (ALI) is still unknown.
47 how exactly RHD3 is involved in the process is still unknown.
48 e origin of this remarkable catalytic effect is still unknown.
49 infection, however its role in HCV infection is still unknown.
50 s diagnosed with major psychiatric disorders is still unknown.
51 ins participating in Abeta-induced signaling is still unknown.
52 ever, the role of STING in adaptive immunity is still unknown.
53 nerates these rhythms and their interactions is still unknown.
54 s mast cells, the underlying pathophysiology is still unknown.
55 However, the intimate mechanism is still unknown.
56 ed by limited availability of growth factors is still unknown.
57 pecific role in anthocyanin bioaccessibility is still unknown.
58 y and durability of this treatment over time is still unknown.
59 ow E. coli contributes to inflammation in UC is still unknown.
60 ibutes to the mechanism of neurodegeneration is still unknown.
61 d with this polymorphism in living organisms is still unknown.
62 of the frequency of weekly PA on weight loss is still unknown.
63 oles in apoptosis however, their role in AKI is still unknown.
64 ally regulated decrease in miR156 expression is still unknown.
65 nd bioactive properties beneficial to health is still unknown.
66 factor Helios, but its role in Treg function is still unknown.
67 in other organs, however, their role in CKD is still unknown.
68 er stroke, its precise neuroanatomical basis is still unknown.
69 are combined to assess an object's stiffness is still unknown.
70 obiomes to obtain their beneficial functions is still unknown.
71 ity for the development of psychotic illness is still unknown.
72 -H1 expressing tumor-reactive CD8(+) T cells is still unknown.
73 thout further degradation via beta-oxidation is still unknown.
74 KI) but without life-threatening indications is still unknown.
75 ffectiveness of emotional memory suppression is still unknown.
76 m to modulate the composition of the capsule is still unknown.
77 gy plays a vital role during these processes is still unknown.
78 responses during visceral leishmaniasis (VL) is still unknown.
79 these chemicals through the use of teethers is still unknown.
80 However, the genetic basis is still unknown.
81 the detailed nature of these rearrangements is still unknown.
82 fect of TREM-1 on NLRP3 inflammasome and ALI is still unknown.
83 exact mechanism behind this satiating effect is still unknown.
84 torms will evolve in a future warmer climate is still unknown.
85 ugh their involvement in acquired resistance is still unknown.
86 ic silencing of the gene by a mechanism that is still unknown.
87 he physiological relevance of these findings is still unknown.
88 modes of transmission are exploited in vivo is still unknown.
89 f this interaction in prostate tumorigenesis is still unknown.
90 tionship between legalization and prevalence is still unknown.
91 this chronic inflammation, but the mechanism is still unknown.
92 NA depletion syndrome, the function of MPV17 is still unknown.
93 ostnatal growth, its precise biological role is still unknown.
94 lp explain such potent neurological activity is still unknown.
95 cular mechanism of (18)F-NaF vascular uptake is still unknown.
96 the amphipathic C-terminal tail of Atlastin is still unknown.
97 role in neighboring endothelial cells (ECs) is still unknown.
98 tion in the pathogenesis of bronchial asthma is still unknown.
99 ), the genetic cause for the majority of CSD is still unknown.
100 is critical for tumor growth and metastasis, is still unknown.
101 rocessing underlying interocular suppression is still unknown.
102 many mRNAs to their subcellular destinations is still unknown.
103 However, the optimal SBP goal following EVT is still unknown.
104 The pathogenesis of fibromyalgia is still unknown.
105 elates of protected area coverage on islands is still unknown.
106 nervous system (CNS), the aetiology of which is still unknown.
107 gic circuit involved in stress vulnerability is still unknown.
108 The origin of LAM cells is still unknown.
109 However, the way the enzyme activates O(2) is still unknown.
110 es to Alzheimer's disease (AD) pathogenesis, is still unknown.
111 III) supports temporal associative learning is still unknown.
112 ghly conserved central domain of the protein is still unknown.
113 in adult (somatic) stem cell differentiation is still unknown.
114 formation and elimination during development is still unknown.
115 the CR to control osmoregulation in lampreys is still unknown.
116 ized, the function of miRNA-128-3p (miR-128) is still unknown.
117 ness, its persistence in an upright position is still unknown.
118 observed regardless of conscious perception is still unknown.
119 king for those with high psychopathic traits is still unknown.
120 c role of T1 in predicting disease worsening is still unknown.
121 role that this mutation plays in oncogenesis is still unknown.
122 in the same membrane or different membranes is still unknown.
123 ection by RIPC, but the underlying mechanism is still unknown.
124 AM riboswitches, but the structure of SAM-IV is still unknown.
125 l evolves within highly organized epithelium is still unknown.
126 cleation in the formation of nuclear domains is still unknown.
127 (PFC) or hippocampus (HP) to these deficits is still unknown.
128 ing that the RNA-binding specificity of FMRP is still unknown.
129 ural factors, but the structure of catatonia is still unknown.
130 ia and its role in oxidative phosphorylation is still unknown.
131 be involved in repressing TEs in germ cells is still unknown.
132 s, how mechanical forces actuate the process is still unknown.
133 m by which cohesin rings are loaded onto DNA is still unknown.
134 (CSF), but the precise route of CSF drainage is still unknown.
135 r, how the jelly facilitates transfer of RNA is still unknown.
136 how phytohormones regulate SVT regeneration is still unknown.
137 lycosylation pathway to disease pathogenesis are still unknown.
138 wever, the final degradation products of ATO are still unknown.
139 regulating this pathway during pluripotency are still unknown.
140 exhibit variable pathologies and phenotypes are still unknown.
141 aintain barrier integrity at postnatal stage are still unknown.
142 mechanism determining the reaction kinetics are still unknown.
143 d decreased height, but the causal mutations are still unknown.
144 ctions and functions of these three proteins are still unknown.
145 s platelets to respond to subsequent stimuli are still unknown.
146 owever, the mechanisms driving these defects are still unknown.
147 ch cognitive functioning seems preponderant, are still unknown.
148 d by fire, and the long-term effects of fire are still unknown.
149 mechanisms driving epigenetic accessibility are still unknown.
150 its further correlation with CSU phenotypes are still unknown.
151 Yet the mechanisms of action are still unknown.
152 tic properties of this important interaction are still unknown.
153 insensitivity in patients with severe asthma are still unknown.
154 reates a painful experience from nociception are still unknown.
155 splicing branchpoints, but many branchpoints are still unknown.
156 or functional mutations in other genes that are still unknown.
157 ed prior knowledge serving these predictions are still unknown.
158 ical roles in the female reproductive system are still unknown.
159 nd many, possibly most, of the disease genes are still unknown.
160 These pathways are still unknown.
161 gnals involved in these demographic declines are still unknown.
162 ncertainty, the underlying neural mechanisms are still unknown.
163 nd temporal occurrence in the disease course are still unknown.
164 itional, nonenzymatic factors, some of which are still unknown.
165 ponsible for pro-OCN cleavage in osteoblasts are still unknown.
166 y syndrome coronavirus (MERS-CoV) infections are still unknown.
167 this phenomenon but responsible compound(s) are still unknown.
168 tability, and therefore downstream functions are still unknown.
169 ispose to rhabdoid tumors versus schwannomas are still unknown.
170 iological role of mitochondria-bound tubulin are still unknown.
171 eractions of many deep-sea pelagic organisms are still unknown.
172 riations in mycobacterial strains themselves are still unknown.
173 lammation and synaptic alterations in MS/EAE are still unknown.
174 he onset and the spreading of these diseases are still unknown.
175 mponents of allantoin export from root cells are still unknown.
176 ents underlying the gating of these channels are still unknown.
177 ition of clouds and its formation mechanisms are still unknown.
178 obesity syndromes but its downstream targets are still unknown.
179 esults and their relative levels of accuracy are still unknown.
180 nd marine biodiversity distribution patterns are still unknown.
181 d which changes they trigger in the channel, are still unknown.
182 However, their mechanistic details are still unknown.
183 onse to environmental risk factors of asthma are still unknown.
184 ever, the proteins involved in such transfer are still unknown.
185 e optimal acoustic settings for sonoporation are still unknown.
186 astrocyte diversity and circuit specificity are still unknown.
187 mechanisms behind this intriguing phenomenon are still unknown.
188 of the intermediates in the binding process are still unknown.
189 n and their possible interaction with CaV1.2 are still unknown.
190 pounds, whose complete biosynthetic pathways are still unknown.
191 design, and the responsible milk components are still unknown.
192 e responsible for anaerobic MTBE degradation are still unknown.
193 tive computations to estimate values online, are still unknown.
194 ement; however, its impacts on N2O emissions are still unknown.
195 mediated oxidative stress in PD pathogenesis are still unknown.
196 and progression in Alzheimer's disease (AD) are still unknown.
197 markers for patient selection and monitoring are still unknown.
198 S/FOXO targets that regulate these functions are still unknown.
199 s relationship to other Alzheimer biomarkers are still unknown.
200 erformance, the electrode failure mechanisms are still unknown.
201 tes, but the functions of most circular RNAs are still unknown.
202 oon size using second generation cryoballoon are still unknown.
203 the voltage change and interacts with anions are still unknown.
204 aining chromatin interactions; however, many are still unknown.
205 actors, including the precise cutting sites, are still unknown.
206 ccess of haematopoietic cell transplantation are still unknown.
207 rogress in proteomics most protein complexes are still unknown.
208 ng the temporal properties of tic expression are still unknown.
209 ed, its effects on cortical dendritic arbors are still unknown.
210 enzymes involved in this fascinating process are still unknown.
211 lating the gene-specific expression of tRNAs are still unknown.
212 ctivation and early osmotic stress signaling are still unknown.
213 s that drive these stalling events, however, are still unknown.
214 n markers and the wine-bottle-closure system are still unknown.
215 h which omalizumab induces adverse reactions are still unknown.
216 hogenesis; however, its biological functions are still unknown.
217 n and its activation under stress conditions are still unknown.
218 ute and long-term consequences of SARS-CoV-2 are still unknown.
219 occur in normal cells prior to tumorigenesis are still unknown.
220 lular mechanisms underlying this progression are still unknown.
221 the effects of microbial dysbiosis on glioma are still unknown.
222 uctivity changes, global changes in tau(eco) are still unknown.
223 osystems, but many details of larval ecology are still unknown.
224 anifestation of the SHFYNG disease phenotype are still unknown.
225 sm in the kidney and the potential mechanism are still unknown.
226 onses that stimulate primary root elongation are still unknown.
227 an integral part of ER protein homeostasis, are still unknown.
228 components that activate RD26 during drought are still unknown.
229 /release pathways of hepatitis B virus (HBV) are still unknown.
230 ctional implications of this genetic control are still unknown.
231 wever, the mechanisms behind this phenomenon are still unknown.
232 cardiovascular lesions during KD vasculitis are still unknown.
233 and influent composition for CaP granulation are still unknown.
234 powder to formulate filled milk powder (FMP) are still unknown.
235 cular mechanism of amino acid phloem loading was still unknown.
236 act with particular viral RNAs, most of them being still unknown.
237 in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the developmen
239 el with which to study NiV disease, but much is still unknown about the viral determinants of NiV pat
240 for banned or restricted chemicals, but much is still unknown about their metabolism and occurrence i
241 d its potential role as a therapeutic target are still unknown, although it has been reported that hu
242 mal dosage for treating voice symptoms in SD are still unknown and require further systematic study.
244 ical relevance, the origin of the phenomenon is still unknown, and as a rare, phenotypically resistan
245 of patients with PPGL-polycythemia syndromes is still unknown, and because these tumors (in most pati
246 However, the optimal temperature for HT is still unknown, and few preclinical studies have compa
247 ast growth factor receptor 2 (FGFR2) kinase, is still unknown, as the numerous crystal structures of
248 acne-involved pilosebaceous epithelial cells are still unknown because almost all sebaceous follicles
249 nosis and treatment of Hodgkin lymphoma (HL) are still unknown because large longitudinal studies of
250 of the fourth Sgl, L from bacteriophage MS2, is still unknown, but we review evidence indicating that
251 uts, but its synaptic organization in humans is still unknown due to the difficulties involved studyi
252 direction and magnitude of net forest change is still unknown due to the large uncertainties in satel
254 and connectivity of migratory species, which are still unknown for hundreds of taxa, especially Asian
256 SICM, several aspects of the imaging process are still unknown; for example, there is still no accura
258 the motor homunculus was first proposed, it is still unknown how different body parts are intermixed
260 genesis have been identified and studied, it is still unknown how genetic and molecular regulation of
266 man-driven decline in fires on the other, it is still unknown how the complex interplay between clima
268 A very large number of metabolites however are still unknown; i.e., their spectroscopic signatures
271 he Cx43 residues that undergo ubiquitination are still unknown, in this study we address other unreso
274 of the Cav1.233L channels in neonatal heart is still unknown, our report demonstrates the ability of
276 ed with heightened cardiovascular risk, much is still unknown regarding its pathophysiology and manag
280 ionary steps leading to the derived activity are still unknown, such pleiotropy suggests that enhance
281 Although the molecular mechanistic link is still unknown, the question whether or not acetaminop
282 in congeners exert their inhalatory toxicity is still unknown, this represents a step toward demonstr
283 viral genes for KSHV lytic reactivation, it is still unknown to what extent RTA alters the host tran
285 However, the reasons of this variability are still unknown.We have characterized the structure of
290 sensory stress signals in sweat; however, it is still unknown whether endogenous neuromodulators such
291 ong-range insulators in the viral genome, it is still unknown whether host transcription factors can
298 been documented in peripheral axons, but it is still unknown whether this localized organelle partic